You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-MAP3K7 (MAP3K7) Antikörper

Bezeichnung:
anti-Mitogen-Activated Protein Kinase Kinase Kinase 7 Antikörper (MAP3K7)
Auf www.antikoerper-online.de finden Sie aktuell 185 Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) Antikörper von 15 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen MAP3K7 Kits (10) und MAP3K7 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 220 MAP3K7 Produkte verfügbar.
Synonyme:
B430101B05, C87327, MEKK7, si:ch211-225h9.1, TAK1, TGF1a, zgc:110612

Meistgesuchte Reaktivitäten zu anti-MAP3K7 (MAP3K7) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Rat (Rattus) MAP3K7 Antikörper:

anti-Human MAP3K7 Antikörper:

anti-Mouse (Murine) MAP3K7 Antikörper:

Alle verfügbaren anti-MAP3K7 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-MAP3K7 Antikörper

  1. Human Polyclonal MAP3K7 Primary Antibody für EIA - ABIN358291 : Ono, Ohtomo, Ninomiya-Tsuji, Tsuchiya: A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. in Biochemical and biophysical research communications 2003 (PubMed)
    Zeige alle 5 Referenzen für ABIN358291

  2. Human Polyclonal MAP3K7 Primary Antibody für EIA, IHC (p) - ABIN360354 : Takaesu, Surabhi, Park, Ninomiya-Tsuji, Matsumoto, Gaynor: TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. in Journal of molecular biology 2003 (PubMed)
    Zeige alle 5 Referenzen für ABIN360354

  3. Human Polyclonal MAP3K7 Primary Antibody für DB, EIA - ABIN358312 : Smit, Baas, Kuipers, Korswagen, van de Wetering, Clevers: Wnt activates the Tak1/Nemo-like kinase pathway. in The Journal of biological chemistry 2004 (PubMed)
    Zeige alle 5 Referenzen für ABIN358312

  4. Human Polyclonal MAP3K7 Primary Antibody für ELISA, WB - ABIN185640 : Omori, Matsumoto, Sanjo, Sato, Akira, Smart, Ninomiya-Tsuji: TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. in The Journal of biological chemistry 2006 (PubMed)
    Zeige alle 2 Referenzen für ABIN185640

  5. Human Polyclonal MAP3K7 Primary Antibody für IHC, ELISA - ABIN1532056 : Mungall, Palmer, Sims, Edwards, Ashurst, Wilming, Jones, Horton, Hunt, Scott, Gilbert, Clamp, Bethel, Milne, Ainscough, Almeida, Ambrose, Andrews, Ashwell, Babbage, Bagguley, Bailey, Banerjee, Barker et al.: The DNA sequence and analysis of human chromosome 6. ... in Nature 2003 (PubMed)
    Zeige alle 2 Referenzen für ABIN1532056

  6. Human Polyclonal MAP3K7 Primary Antibody für ELISA, WB - ABIN1532055 : Shibuya, Yamaguchi, Shirakabe, Tonegawa, Gotoh, Ueno, Irie, Nishida, Matsumoto: TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. in Science (New York, N.Y.) 1996 (PubMed)
    Zeige alle 2 Referenzen für ABIN1532055

  7. Human Polyclonal MAP3K7 Primary Antibody für EIA, WB - ABIN500865 : Yamaguchi, Shirakabe, Shibuya, Irie, Oishi, Ueno, Taniguchi, Nishida, Matsumoto: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. in Science (New York, N.Y.) 1996 (PubMed)

Weitere Antikörper gegen MAP3K7 Interaktionspartner

Human Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) Interaktionspartner

  1. This study suggests that aberrant activity of TAK1 impairs autophagy and subsequently leads to alterations in the vitality of retinal pigment epithelial cells.

  2. TAK1 may be an important factor involved in the pathogenesis of thyroid cancer, and targeted down-regulation of TAK1 may improve the prognosis of patients with thyroid cancer.

  3. Loss of MAP3K7 are associated with esophageal squamous cell carcinoma.

  4. This paper highlights that targeting the BMP and TGFbeta (zeige TGFB1 Antikörper) type I and type II receptors causes a downregulation of XIAP (zeige XIAP Antikörper), TAK1, and Id1 (zeige ID1 Antikörper) leading to cell death of lung cancer cells.

  5. Polyubiquitination of Transforming Growth Factor beta-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4 (zeige TLR4 Antikörper)-mediated JNK (zeige MAPK8 Antikörper) and p38 MAPK (zeige MAPK14 Antikörper) Activation

  6. The data emphasize the central role of TAK1 in controlling signaling cascades and functional responses in primary neutrophils, making it a promising target for therapeutic intervention in view of the role of neutrophils in chronic inflammatory conditions.

  7. MiR (zeige MLXIP Antikörper)-377 is an important negative regulator of E2F (zeige E2F1 Antikörper) and MAP3K7/NF-kB signaling pathway in melanoma cells.

  8. the TAK1 signaling pathway may represent a suitable target to design new, antifibrotic therapies

  9. Findings indicate that SHIP2 (zeige INPPL1 Antikörper) is a regulator of lymphatic function in humans and that inherited mutations in the INPPL1 (zeige INPPL1 Antikörper) gene may act in concert with HGF (zeige HGF Antikörper), and likely MAP3K7, mutations to exacerbate lymphatic phenotypes.

  10. Data indicate that inhibition of TGF-beta (zeige TGFB1 Antikörper)-activated protein kinase (zeige CDK7 Antikörper) 1 (TAK1) reduces chemokine (C-C motif) receptor 7 (CCR7 (zeige CCR7 Antikörper)) expression.

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) Interaktionspartner

  1. TAK1 (zeige NR2C2 Antikörper) signaling preserved the viability of lambda-chain-positive B cells by maintaining Bcl-2 (zeige BCL2 Antikörper) expression through IKK (zeige CHUK Antikörper)-NF-kappaB (zeige NFKB1 Antikörper) signaling

  2. Data show that TGFbeta (zeige TGFB1 Antikörper)-activated kinase-1 (TAK1 (zeige NR2C2 Antikörper)) activated nuclear factor of activated T-cells (NFAT (zeige NFATC1 Antikörper))/NF-kappa B (NFkappaB (zeige NFKB1 Antikörper)), downregulated BCL2-adenovirus E1B interacting protein 3 (Bnip3 (zeige BNIP3 Antikörper)), and inhibited cardiac cell death.

  3. Crucial functions of inflammatory TAK1 (zeige NR2C2 Antikörper)-NEMO (zeige IKBKG Antikörper) signaling in protecting the brain endothelium and maintaining normal brain function.

  4. Roles of TAK1 (zeige NR2C2 Antikörper) in vascular oxidative stress and its contribution to neointima formation after vascular injury.

  5. Inactivation of TAK1 (zeige NR2C2 Antikörper) in satellite cells inhibits muscle regeneration in adult mice.

  6. our current study highlighted the emerging role of TAK1 (zeige NR2C2 Antikörper) in configuring the gut (zeige GUSB Antikörper)-specialized T cell subset, which regulates mucosal homeostasis under lymphopenic conditions.

  7. the ADAP (zeige APP Antikörper) CARMA1 (zeige CARD11 Antikörper) binding site is required for IKK gamma (zeige IKBKG Antikörper) ubiquitination; both TAK1 (zeige NR2C2 Antikörper) and CARMA1 (zeige CARD11 Antikörper) binding sites are required for IkappaB alpha (zeige NFKBIA Antikörper) phosphorylation and degradation and NF-kappaB (zeige NFKB1 Antikörper) nuclear translocation

  8. Results provide evidence that TAK1 (zeige NR2C2 Antikörper) is required for the activation of NF-kappaB (zeige NFKB1 Antikörper) in thymocytes and suggest that TAK1 (zeige NR2C2 Antikörper) plays a central role in both innate and adaptive immunity.

  9. TAK1 (zeige NR2C2 Antikörper) is essential for connective tissue deposition in the dermis.

  10. Tak1 functions to regulate tongue development by controlling Fgf10 expression and could represent a candidate gene for mutation in human PRS clefting.

MAP3K7 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2\; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.

Alternative names and synonyms associated with MAP3K7

  • mitogen activated protein kinase kinase kinase 7 (map3k7) Antikörper
  • mitogen activated protein kinase kinase kinase 7 (Map3k7) Antikörper
  • mitogen-activated protein kinase kinase kinase 7 (MAP3K7) Antikörper
  • mitogen-activated protein kinase kinase kinase 7 (Map3k7) Antikörper
  • B430101B05 Antikörper
  • C87327 Antikörper
  • MEKK7 Antikörper
  • si:ch211-225h9.1 Antikörper
  • TAK1 Antikörper
  • TGF1a Antikörper
  • zgc:110612 Antikörper

Bezeichner auf Proteinebene für MAP3K7

mitogen-activated protein kinase kinase kinase 7 , tak1 , TGF-beta-activated kinase TAK1 , TGF-beta activated kinase 1 , TGF-beta-activated kinase 1 , transforming growth factor-beta-activated kinase 1 , mitogen activated protein kinase kinase kinase 7 , transforming growth factor beta-activated kinase 1

GENE ID SPEZIES
553788 Danio rerio
313121 Rattus norvegicus
6885 Homo sapiens
26409 Mus musculus
529146 Bos taurus
100171454 Pongo abelii
Ausgewählte Anbieter für anti-MAP3K7 (MAP3K7) Antikörper
Haben Sie etwas anderes gesucht?